Table: Kobayashi Pharmaceutical -2022 group results

Kobayashi Pharmaceutical

14/02/2023 06:00

Feb 14 (Reuters)- 
          Kobayashi Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Dec 31, 2022    Dec 31, 2021   Dec 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            166.26          155.25         172.00                 
                 (+7.1 pct)      (+3.1 pct)     (+3.5 pct)               
  Operating         26.67           26.07          25.50                 
                 (+2.3 pct)      (+0.5 pct)     (-4.4 pct)               
  Recurring         28.28           28.02          26.50                 
                 (+1.0 pct)      (+1.0 pct)     (-6.3 pct)               
  Net
  Net               20.02           19.72          20.20                 
                 (+1.6 pct)      (+2.7 pct)     (+0.9 pct)               
  EPS            259.63 yen      252.36 yen     265.74 yen               
  EPS Diluted    259.59 yen                                              
  Ann Div         90.00 yen       83.00 yen      92.00 yen               
  -Q2 Div         38.00 yen       37.00 yen      39.00 yen               
  -Q4 Div         52.00 yen       46.00 yen      53.00 yen               
  
  NOTE - Kobayashi Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T